N. J. Pearson
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Endocrinology top 5%
- Vibrio bacteria research studies
Papers in
-
- Antibiotic Resistance in Bacteria 8
-
- Vibrio bacteria research studies 4
- Co-authors
- P. IspahaniDarren C. GreenwoodF. O’GradyK. J. TownerW. R. CattellFred MhaluR. W. HedgesM.J. Lewis
- Journals
- Journal of Antimicrobial Chemotherapy (3 papers)Journal of Epidemiology & Community Health (1 paper)QJM (1 paper)The Lancet (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- United KingdomFrance
In The Last Decade
N. J. Pearson
16 papers receiving 382 citations
Peers
Comparison fields: 5 of 71
- Molecular Medicine 135
- Endocrinology 95
- Applied Microbiology and Biotechnology 34
- Clinical Biochemistry 71
- Critical Care and Intensive Care Medicine 48
Countries citing papers authored by N. J. Pearson
This map shows the geographic impact of N. J. Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. J. Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. J. Pearson more than expected).
Fields of papers citing papers by N. J. Pearson
This network shows the impact of papers produced by N. J. Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. J. Pearson. The network helps show where N. J. Pearson may publish in the future.
Co-authorship network
The 17 scholars most cited alongside N. J. Pearson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 16 | |
| 2 | 1989 | 8 | |
| 3 | Blood cultures: eight years' experience of a conventional in-house system and trends in antimicrobial susceptibilities. | 1989 | 7 |
| 4 | 1987 | 47 | |
| 5 | An analysis of community and hospital-acquired bacteraemia in a large teaching hospital in the United Kingdom. | 1987 | 121 |
| 6 | 1980 | 39 | |
| 7 | 1980 | 2 | |
| 8 | Resistance to antimicrobial agents of Vibrio cholerae E1 Tor strains isolated during the fourth cholera epidemic in the United Republic of Tanzania. | 1980 | 34 |
| 9 | 1979 | 27 | |
| 10 | 1979 | 23 | |
| 11 | 1977 | 31 | |
| 12 | R plasmids from Asian strains of Vibrio cholerae. Antimicrob. | 1977 | 2 |
| 13 | 1977 | 1 | |
| 14 | Global surveillance of antibiotic sensitivity of Vibrio cholerae. | 1976 | 20 |
| 15 | 1976 | 21 | |
| 16 | 1966 | 29 |
About N. J. Pearson
N. J. Pearson is a scholar working on Molecular Medicine, Endocrinology, Applied Microbiology and Biotechnology, Critical Care and Intensive Care Medicine and Clinical Biochemistry, having authored 16 papers that have together received 428 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (8 papers), Urinary Tract Infections Management (5 papers), Salmonella and Campylobacter epidemiology (5 papers), Vibrio bacteria research studies (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Bacterial Identification and Susceptibility Testing (2 papers), Nosocomial Infections in ICU (2 papers) and Neutropenia and Cancer Infections (1 paper). The work is most often cited by research in Molecular Medicine (135 citations), Endocrinology (95 citations), Applied Microbiology and Biotechnology (34 citations), Clinical Biochemistry (71 citations) and Critical Care and Intensive Care Medicine (48 citations). N. J. Pearson has collaborated with scholars based in United Kingdom and France. Frequent co-authors include P. Ispahani, Darren C. Greenwood, F. O’Grady, K. J. Towner, W. R. Cattell, Fred Mhalu, R. W. Hedges, M.J. Lewis, David Greenwood and J. R. Ashford. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Journal of Epidemiology & Community Health, QJM, The Lancet and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.